Programs Project for Medical Innovation Ecosystem

Overview

Strengthens R&D support for companies engaged in drug discovery, from pre-clinical to clinical trial stages, with hands-on support from venture capital investors. Promotes the establishment of a drug discovery ecosystem, by fostering research and development through collaboration among industry, academia, and government, aiming to create innovative pharmaceuticals and medical devices.

List of our Programs

Programs Overview
Strengthening Program for Pharmaceutical Startup Ecosystem Under the "Strategy for Strengthening Vaccine Development and Production Systems" approved by the Cabinet in June 2021, this Program was established to support pharmaceutical startup companies engaged in the commercialization and development of technologies related to vaccines and therapeutics for infectious diseases.
Alliance program for Innovative Medical/healthcare research by Government-Academia-Industry Collaboration The program aims to conduct the research and development with the collaboration of several academia and companies. The program is supported by matching funds of multiple years (up to 5 years) which consist of national funds (government expense) and private funds from companies. The results of the program is expected to achieve the development of pharmaceuticals and medical devices (and so on) by the companies.

Last updated 09/30/25